154 related articles for article (PubMed ID: 27055871)
1. Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.
Spinner S; Crispatzu G; Yi JH; Munkhbaatar E; Mayer P; Höckendorf U; Müller N; Li Z; Schader T; Bendz H; Hartmann S; Yabal M; Pechloff K; Heikenwalder M; Kelly GL; Strasser A; Peschel C; Hansmann ML; Ruland J; Keller U; Newrzela S; Herling M; Jost PJ
Leukemia; 2016 Jul; 30(7):1520-30. PubMed ID: 27055871
[TBL] [Abstract][Full Text] [Related]
2. Survival control of malignant lymphocytes by anti-apoptotic MCL-1.
Fernández-Marrero Y; Spinner S; Kaufmann T; Jost PJ
Leukemia; 2016 Nov; 30(11):2152-2159. PubMed ID: 27479182
[TBL] [Abstract][Full Text] [Related]
3. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
[TBL] [Abstract][Full Text] [Related]
4. [A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin's lymphoma].
Zuo XL; Zhou X; Meng J; Zhang KJ; Liu XH; Yang HQ
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):133-5. PubMed ID: 16624124
[TBL] [Abstract][Full Text] [Related]
5. MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice.
Grabow S; Delbridge AR; Valente LJ; Strasser A
Blood; 2014 Dec; 124(26):3939-46. PubMed ID: 25368374
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
7. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
Montraveta A; Xargay-Torrent S; Rosich L; López-Guerra M; Roldán J; Rodríguez V; Lee-Vergés E; de Frías M; Campàs C; Campo E; Roué G; Colomer D
Oncotarget; 2015 Aug; 6(25):21159-72. PubMed ID: 26110568
[TBL] [Abstract][Full Text] [Related]
9. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MCL-1 by obatoclax sensitizes Sp2/0-Ag14 hybridoma cells to glutamine deprivation-induced apoptosis.
Harnett CC; Abusneina A; Clément J; Gauthier ER
Cell Biochem Funct; 2015 Jul; 33(5):334-40. PubMed ID: 26178811
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by Ginkgo biloba (EGb761) in melanoma cells is Mcl-1-dependent.
Wang Y; Lv J; Cheng Y; Du J; Chen D; Li C; Zhang J
PLoS One; 2015; 10(4):e0124812. PubMed ID: 25860257
[TBL] [Abstract][Full Text] [Related]
12. Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199).
Phillips DC; Xiao Y; Lam LT; Litvinovich E; Roberts-Rapp L; Souers AJ; Leverson JD
Blood Cancer J; 2015 Nov; 5(11):e368. PubMed ID: 26565405
[TBL] [Abstract][Full Text] [Related]
13. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Willimott S; Baou M; Naresh K; Wagner SD
Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
[TBL] [Abstract][Full Text] [Related]
14. Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim.
Nguyen M; Cencic R; Ertel F; Bernier C; Pelletier J; Roulston A; Silvius JR; Shore GC
BMC Cancer; 2015 Aug; 15():568. PubMed ID: 26231047
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.
Glaser SP; Lee EF; Trounson E; Bouillet P; Wei A; Fairlie WD; Izon DJ; Zuber J; Rappaport AR; Herold MJ; Alexander WS; Lowe SW; Robb L; Strasser A
Genes Dev; 2012 Jan; 26(2):120-5. PubMed ID: 22279045
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cytokine withdrawal-induced apoptosis by Mcl-1 requires interaction between Mcl-1 and Bim.
Jamil S; Wang SW; Bondy L; Mojtabavi S; Duronio V
Biochem Cell Biol; 2010 Oct; 88(5):809-18. PubMed ID: 20921992
[TBL] [Abstract][Full Text] [Related]
18. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
19. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S
Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698
[TBL] [Abstract][Full Text] [Related]
20. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.
Schlaifer D; Krajewski S; Galoin S; Rigal-Huguet F; Laurent G; Massip P; Pris J; Delsol G; Reed JC; Brousset P
Am J Pathol; 1996 Jul; 149(1):177-85. PubMed ID: 8686741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
